July 30 (Reuters) - Avenira Ltd (AEV) :
- STRATEGIC INVESTMENT FROM SICHUAN HEBANG BIOTECHNOLOGY
- INVESTMENT COMPRISES A$4.5 MILLION 2-TRANCHE PLACEMENT AT ISSUE PRICE OF A$0.006 PER NEW SHARE, AMONG OTHERS
- AS PART OF INVESTMENT, HEBANG HAS RIGHT TO APPOINT EXECUTIVE CHAIRMAN TO BOARD, AND A CEO AND CFO TO MANAGEMENT TEAM
- FOLLOWING COMPLETION OF TRANCHE 1, CO WILL APPOINT MO YANG AS EXECUTIVE CHAIRMAN AND CEO
(([email protected];))
July 30 (Reuters) - Avenira Ltd (AEV) : STRATEGIC INVESTMENT...
-
- There are more pages in this discussion • 7 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AEV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.2¢ |
Change
0.001(9.09%) |
Mkt cap ! $32.44M | |||
| Open | High | Low | Value | Volume |
| 1.1¢ | 1.2¢ | 1.1¢ | $11.97K | 1.023M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1221544 | 1.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.2¢ | 321265 | 2 |
View Market Depth
| Last trade - 16.10pm 09/09/2024 (20 minute delay) ? |
| AEV (ASX) Chart |